Gary G Gemignani - Net Worth and Insider Trading

Gary G Gemignani Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gary G Gemignani owns 3 companies in total, including Synergy Pharmaceuticals Inc (SGYPQ) , Albireo Pharma Inc (ALBO) , and Bluejay Diagnostics Inc (BJDX) .

Click here to see the complete history of Gary G Gemignani’s form 4 insider trades.

Insider Ownership Summary of Gary G Gemignani

Ticker	Comapny	Transaction Date	Type of Owner
SGYPQ	Synergy Pharmaceuticals Inc	2018-01-19	Executive Vice Pres. & CFO
ALBO	Albireo Pharma Inc	2014-09-15	Chief Financial Officer
BJDX	Bluejay Diagnostics Inc	2021-11-13	director

Gary G Gemignani Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gary G Gemignani Ownership Network

Ownership Network List of Gary G Gemignani

No Data

Ownership Network Relation of Gary G Gemignani

Gary G Gemignani Owned Company Details

What does Synergy Pharmaceuticals Inc do?

Who are the key executives at Synergy Pharmaceuticals Inc?

Gary G Gemignani is the Executive Vice Pres. & CFO of Synergy Pharmaceuticals Inc. Other key executives at Synergy Pharmaceuticals Inc include director & Executive Chairman Gary S Jacob , 10 percent owner Paulson & Co. Inc. , and Senior Vice President & Finance Bernard Denoyer .

Synergy Pharmaceuticals Inc (SGYPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Synergy Pharmaceuticals Inc (SGYPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synergy Pharmaceuticals Inc Insider Transactions

No Available Data

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Gary G Gemignani is the Chief Financial Officer of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

Over the past 18 months, Gary G Gemignani made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

What does Bluejay Diagnostics Inc do?

Who are the key executives at Bluejay Diagnostics Inc?

Gary G Gemignani is the director of Bluejay Diagnostics Inc. Other key executives at Bluejay Diagnostics Inc include director & 10 percent owner Svetlana Dey , director & 10 percent owner & Chief Technology Officer Indranil Dey , and CFO Frances P Scally .

Bluejay Diagnostics Inc (BJDX) Insider Trades Summary

Over the past 18 months, Gary G Gemignani made no insider transaction in Bluejay Diagnostics Inc (BJDX). Other recent insider transactions involving Bluejay Diagnostics Inc (BJDX) include a net purchase of 10,500 shares made by Indranil Dey , and a net purchase of 10,500 shares made by Svetlana Dey .

In summary, during the past 3 months, insiders sold 0 shares of Bluejay Diagnostics Inc (BJDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bluejay Diagnostics Inc (BJDX) were sold and 2,000 shares were bought by its insiders, resulting in a net purchase of 2,000 shares.

Bluejay Diagnostics Inc (BJDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bluejay Diagnostics Inc Insider Transactions

No Available Data

Gary G Gemignani Mailing Address

Above is the net worth, insider trading, and ownership report for Gary G Gemignani. You might contact Gary G Gemignani via mailing address: C/o Iaso Pharma Inc., 12707 High Bluff Drive, Suite 200, San Diego Ca 92130.

Discussions on Gary G Gemignani

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.